Leiomyosarcoma
📧 Sign up to get email alerts when something new happens for Leiomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
Phase 2 clinical trial evaluating tabelecleucel in EBV-associated diseases is active/not recruiting, focusing on EBV+ LPD and related condit…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma [Phase 2]
A Phase 2 clinical trial update describes testing the combination of ipilimumab and nivolumab with or without cabozantinib in adults with ad…
-
CLINICAL_TRIALS other · 2026-04-21Clinical Trial Update: STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas [Phase 1, Phase 2]
This clinical trial update notes recruitment for STC-15 in combination with toripalimab for selected advanced cancers and as monotherapy in …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) [Phase 3]
Phase 3 clinical trial ARGSARC evaluating ADI-PEG 20 or placebo plus gemcitabine and docetaxel in previously treated leiomyosarcoma (soft ti…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) [Phase 3]
A Phase 3 trial is evaluating lurbinectedin plus doxorubicin versus doxorubicin alone as first-line treatment for metastatic leiomyosarcoma;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding abemaciclib to gemcitabine for soft tissue sarcoma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lurbinectedin + Doxorubicin In Leiomyosarcoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating lurbinectedin in combination with doxorubicin for advanced or metastatic soft-tissue sarcoma, including leiomyo…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma [Phase 1]
Phase 1 trial evaluating the safety of low-dose pegylated liposomal doxorubicin in combination with peposertib for advanced sarcoma; current…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery [Phase 2]
Clinical trial update for a Phase 2 study evaluating Talimogene laherparepvec with radiation therapy in newly diagnosed soft tissue sarcoma …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of Ivonescimab in People With Leiomyosarcoma [Phase 2]
A Phase 2 clinical trial evaluating Ivonescimab for leiomyosarcoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma [Phase 3]
A Phase 3 clinical trial is evaluating whether adding neoadjuvant chemotherapy to surgery improves outcomes for high-risk retroperitoneal sa…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma [Phase 2]
A Phase 2 clinical trial in patients with metastatic or locally advanced leiomyosarcoma (including leiomyosarcoma of the ovary and soft tiss…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma [Phase 1]
Phase 1 trial evaluating nivolumab plus BO-112 as a neoadjuvant treatment before surgery for resectable soft tissue sarcoma, including multi…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions [Phase 1]
Phase I trial evaluating the safety and preliminary activity of combining gemcitabine with nab-sirolimus in adults with advanced Leiomyosarc…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) [Phase 3]
APROMISS is a Phase III trial of combined anlotinib and catequentinib in advanced alveolar soft-part sarcoma, leiomyosarcoma, and synovial s…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
Clinical trial update describing precision medicine approaches for neoadjuvant therapy in high‑risk sarcoma patients; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas [NA]
Investigates regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas and related subtypes. The trial is…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Localized Leiomyosarcoma Biomarker Protocol
This update describes an ongoing biomarker protocol for localized leiomyosarcoma that is currently recruiting. Sponsor: University of Michig…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma [Phase 1, Phase 2]
This update reports the completion and posted results of a Phase 1/2 trial evaluating pembrolizumab in combination with gemcitabine chemothe…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy [NA]
This clinical trial update describes a study for advanced leiomyosarcoma using human organoid-guided personalized efficacy. Enrolment is by …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors [Phase 2]
This notice reports a Phase 2 clinical trial evaluating a PD-L1 inhibitor in combination with strategies targeting DNA damage and angiogenes…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma [Phase 2]
A Phase 2 trial is evaluating the efficacy and tolerability of weekly doxorubicin in elderly patients with advanced or metastatic leiomyosar…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. [Phase 2]
Clinical trial evaluating dose-escalated, hypofractionated definitive proton radiotherapy for patients with inoperable soft tissue sarcoma (…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating hypofractionated, 3-week preoperative radiotherapy using proton or photon therapy for localized sof…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma [Phase 2]
Phase 2 clinical trial of XL092 (Zanzalintinib) for metastatic or unresectable leiomyosarcoma is currently recruiting.